US7743743004 - Common Stock
ROCKWELL MEDICAL INC
NASDAQ:RMTI (4/25/2024, 7:15:00 PM)
After market: 1.51 0 (0%)1.51
+0.02 (+1.34%)
Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. The company is headquartered in Wixom, Michigan and currently employs 253 full-time employees. The company operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. The company is the supplier of life-sustaining hemodialysis concentrates products to dialysis clinics. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream. Its first two branded products from its ferric pyrophosphate citrate (FPC) platform, Triferic (dialysate) and Triferic AVNU, are indicated to maintain hemoglobin in patients undergoing hemodialysis. The company offers dry and liquid citric acid, acetic acid, and bicarbonate hemodialysis products.
ROCKWELL MEDICAL INC
30142 Wixom Road
Wixom MICHIGAN 48393
P: 18004493353
CEO: Russell Ellison
Employees: 253
Website: https://www.rockwellmed.com/
RMTI stock results show that Rockwell Medical beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Rockwell Medical (NASDAQ:RMTI) just reported results for the fourth quarter of ...
Here you can normally see the latest stock twits on RMTI, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: